Journal
VIRCHOWS ARCHIV
Volume 479, Issue 4, Pages 755-764Publisher
SPRINGER
DOI: 10.1007/s00428-021-03110-9
Keywords
Myelofibrosis; Splenectomy; Spleen pathology; Immunohistochemistry; Molecular biology
Categories
Ask authors/readers for more resources
In patients with BCR-ABL fusion-negative myeloproliferative neoplasms (MPNs) and myelofibrosis (MF), megakaryocyte-rich spleen nodules (MRSNs) were significantly associated with megakaryocyte proliferation in the spleen. Twenty out of 28 patients showed increased spleen fibrosis (SF). Comparisons of spleen and bone marrow NGS findings revealed identical mutational status in half of the patients.
BCR-ABL-fusion-negative myeloproliferative neoplasms (MPNs) with myelofibrosis (MF) include primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF. Clonal extramedullary hematopoiesis (EMH) can occur during MPN pathogenesis. Although histopathological bone-marrow (BM) features during clonal EMH have been investigated, those of the spleen have been poorly described. We analyzed splenectomy samples from 28 patients with MF and BM samples from 20 of them. Slides were stained with hematoxylin and eosin, reticulin, and trichrome, with immunohistochemical labeling of glycophorin A, myeloperoxidase, CD61, CD34, and CD117. We also subjected splenectomy and BM samples from six patients and spleen samples from seven patients to next-generation sequencing (NGS). Megakaryocyte-rich spleen nodules (MRSNs), seen in seven of the 28 patients, were significantly associated with megakaryocyte proliferation in the spleen (p = 0.04). We devised a grading system for spleen fibrosis (SF) and found that SF was increased in 20 of 28 patients. Notably, patients with SF were more likely to have MRSNs, suggesting that megakaryocytes might participate in SF, as previously described in BM. Comparisons of spleen and BM NGS findings of six patients' specimens revealed identical mutational status in the two organs for half of the patients. We observed additional mutations in the spleen of two patients. However, the meaning of this finding remains unknown since there was a long interval between BM and spleen samplings (68 and 82 months, respectively).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available